Furthermore, a recent study showed that a high CD3+ to CD4+ ratio in PMs from CRC, i.e. a dominance of CD8+ T cells over conventional CD4+ T helper cells and Treg, correlated with better overall survival following cytoreductive surgery and HIPEC (9). The gene discussed is CD4; the disease is colorectal carcinoma.